Intracellular LINGO-1 negatively regulates Trk neurotrophin receptor signaling

Molecular and Cellular Neuroscience

Volumn 70, Issue , 2016, Pages 1-10

  Meabon, James S ^a,b   de Laat, Rian ^c   Ieguchi, Katsuaki ^d   Serbzhinsky, Dmitry ^e   Hudson, Mark P ^f   Huber, B Russel ^a   Wiley, Jesse C ^f   Bothwell, Mark ^f  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c Immusoft   (United States)

^d TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^e SEATTLE BIOMEDICAL RESEARCH INSTITUTE   (United States)

^f UNIVERSITY OF WASHINGTON   (United States)

Author keywords

LINGO 1; Linx; LRRN6a; TrkA; TrkB; TrkC

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; MEMBRANE PROTEIN; NEUROTROPHIN; NEUROTROPHIN 3 RECEPTOR; PROTEIN LINGO 1; PROTEIN LRIG1; PROTEIN TYROSINE KINASE A; UNCLASSIFIED DRUG; LINGO1 PROTEIN, RAT; NERVE PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CELL VIABILITY; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DENSITOMETRY; DOWN REGULATION; ENDOCYTOSIS; ENDOSOME; FEEDBACK SYSTEM; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOPRECIPITATION; IMMUNOREACTIVITY; INTERNALIZATION; LYSOSOME; MOUSE; NEGATIVE FEEDBACK; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN PURIFICATION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; UPREGULATION; ANIMAL; CYTOPLASM; GENETICS; METABOLISM; PC12 CELL LINE; PHOSPHORYLATION; RAT;

ANIMALS; CYTOPLASM; DOWN-REGULATION; ENDOSOMES; LYSOSOMES; MEMBRANE PROTEINS; NERVE TISSUE PROTEINS; PC12 CELLS; PHOSPHORYLATION; RATS; RECEPTOR, TRKA; RECEPTOR, TRKB; RECEPTOR, TRKC; SIGNAL TRANSDUCTION;

EID: 84946867240     PISSN: 10447431     EISSN: 10959327     Source Type: Journal    
DOI: 10.1016/j.mcn.2015.11.002     Document Type: Article

References (43)

1. Ascaño M., Richmond A., Borden P., Kuruvilla R. Axonal targeting of Trk receptors via transcytosis regulates sensitivity to neurotrophin responses. J. Neurosci. 2009, 29:11674-11685.
2. Bhattacharyya A., Watson F.L., Pomeroy S.L., Zhang Y.Z., Stiles C.D., Segal R.A. High-resolution imaging demonstrates dynein-based vesicular transport of activated Trk receptors. J. Neurobiol. 2002, 51:302-312.
3. Bibel M., Hoppe E., Barde Y.A. Biochemical and functional interactions between the neurotrophin receptors trk and p75NTR. EMBO J. 1999, 18:616-622.
4. Butowt R., von Bartheld C.S. Sorting of internalized neurotrophins into an endocytic transcytosis pathway via the Golgi system: ultrastructural analysis in retinal ganglion cells. J. Neurosci. 2001, 21:8915-8930.
5. Carim-Todd L., Escarceller M., Estivill X., Sumoy L. LRRN6A/LERN1 (leucine-rich repeat neuronal protein 1), a novel gene with enriched expression in limbic system and neocortex. Eur. J. Neurosci. 2003, 18:3167-3182.
6. de Laat R., Meabon J.C., Wiley J.C., Hudsob M.P., Montine T.J., Bothwell M. LINGO-1 promotes lysosomal degradation of amyloid-β protein precursor. Pathobiol Aging Age Relat Dis. 2015, 5:25796.
7. Delay C., Tremblay C., Brochu E., Paris-Robidas S., Emond V., Rajput A.H., Rajput A., Calon F. Increased LINGO1 in the Cerebellum of Essential Tremor Patients 2014, Mov Disord.
8. Fu Q.L., Hu B., Li X., Shao Z., Shi J.B., Wu W., So K.F., Mi S. LINGO-1 negatively regulates TrkB phosphorylation after ocular hypertension. Eur. J. Neurosci. 2010, 31:1091-1097.
9. Geetha T., Wooten M.W. TrkA receptor endolysosomal degradation is both ubiquitin and proteasome dependent. Traffic 2008, 9:1146-1156.
10. Grimes M.L., Zhou J., Beattie E.C., Yuen E.C., Hall D.E., Valletta J.S., Topp K.S., LaVail J.H., Bunnett N.W., Mobley W.C. Endocytosis of activated TrkA: evidence that nerve growth factor induces formation of signaling endosomes. J. Neurosci. 1996, 16:7950-7964.
11. Gumienny T.L., Macneil L., Zimmerman C.M., Wang H., Chin L., Wrana J.L., Padgett R.W. Caenorhabditis elegans SMA-10/LRIG is a conserved transmembrane protein that enhances bone morphogenetic protein signaling. PLoS Genet. 2010 May 20, 6(5).
12. Gur G., Rubin C., Katz M., Amit I., Citri A., Nilsson J., Amariglio N., Henriksson R., Rechavi G., Hedman H., et al. LRIG1 restricts growth factor signaling by enhancing receptor ubiquitylation and degradation. EMBO J. 2004, 23:3270-3281.
13. Heuser J.E., Anderson R.G. Hypertonic media inhibit receptor-mediated endocytosis by blocking clathrin-coated pit formation. J. Cell Biol. 1989, 108:389-400.
14. Huff K., End D., Guroff G. Nerve growth factor-induced alteration in the response of PC12 pheochromocytoma cells to epidermal growth factor. J. Cell Biol. 1981, 88:189-198.
15. Inoue H., Lin L., Lee X., Shao Z., Mendes S., Snodgrass-Belt P., Sweigard H., Engber T., Pepinsky B., Yang L., et al. Inhibition of the leucine-rich repeat protein LINGO-1 enhances survival, structure, and function of dopaminergic neurons in Parkinson's disease models. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:14430-14435.
16. Jiménez-Jiménez F.J., García-Martín E., Lorenzo-Betancor O., Pastor P., Alonso-Navarro H., Agúndez J.A. LINGO1 and risk for essential tremor: results of a meta-analysis of rs9652490 and rs11856808. J. Neurol. Sci. 2012, 317:52-57.
17. Kanning K.C., Hudson M., Amieux P.S., Wiley J.C., Bothwell M., Schecterson L.C. Proteolytic processing of the p75 neurotrophin receptor and two homologs generates C-terminal fragments with signaling capability. J. Neurosci. 2003, 23:5425-5436.
18. Klein R., Parada L.F., Coulier F., Barbacid M. TrkB, a novel tyrosine protein kinase receptor expressed during mouse neural development. EMBO J. 1989, 8:3701-3709.
19. Klinger S.C., Siupka P., Nielsen M.S. Retromer-mediated trafficking of transmembrane receptors and transporters. Membranes (Basel) 2015, 5:288-306.
20. Krig S.R., Frietze S., Simion C., Miller J.K., Fry W.H., Rafidi H., Kotelawala L., Qi L., Griffith O.L., Gray J.W., et al. Lrig1 is an estrogen-regulated growth suppressor and correlates with longer relapse-free survival in ERα-positive breast cancer. Mol. Cancer Res. 2011, 9:1406-1417.
21. Kuo S.H., Tang G., Louis E.D., Ma K., Babji R., Balatbat M., Cortes E., Vonsattel J.P., Yamamoto A., Sulzer D., et al. Lingo-1 expression is increased in essential tremor cerebellum and is present in the basket cell pinceau. Acta Neuropathol. 2013, 125:879-889.
22. Laederich M.B., Funes-Duran M., Yen L., Ingalla E., Wu X., Carraway K.L., Sweeney C. The leucine-rich repeat protein LRIG1 is a negative regulator of ErbB family receptor tyrosine kinases. J. Biol. Chem. 2004, 279:47050-47056.
23. Lazo O.M., Gonzalez A., Ascaño M., Kuruvilla R., Couve A., Bronfman F.C. BDNF regulates Rab11-mediated recycling endosome dynamics to induce dendritic branching. J. Neurosci. 2013, 33:6112-6122.
24. Ledda F., Bieraugel O., Fard S.S., Vilar M., Paratcha G. Lrig1 is an endogenous inhibitor of Ret receptor tyrosine kinase activation, downstream signaling, and biological responses to GDNF. J. Neurosci. 2008, 28:39-49.
25. Lee X., Yang Z., Shao Z., Rosenberg S.S., Levesque M., Pepinsky R.B., Qiu M., Miller R.H., Chan J.R., Mi S. NGF regulates the expression of axonal LINGO-1 to inhibit oligodendrocyte differentiation and myelination. J. Neurosci. 2007, 27:220-225.
26. Lindström A.K., Ekman K., Stendahl U., Tot T., Henriksson R., Hedman H., Hellberg D. LRIG1 and squamous epithelial uterine cervical cancer: correlation to prognosis, other tumor markers, sex steroid hormones, and smoking. Int. J. Gynecol. Cancer 2008, 18:312-317.
27. Lööv C., Fernqvist M., Walmsley A., Marklund N., Erlandsson A. Neutralization of LINGO-1 during in vitro differentiation of neural stem cells results in proliferation of immature neurons. PLoS One 2012, 7.
28. Mandai K., Guo T., St Hillaire C., Meabon J.S., Kanning K.C., Bothwell M., Ginty D.D. LIG family receptor tyrosine kinase-associated proteins modulate growth factor signals during neural development. Neuron 2009, 63:614-627.
29. Meabon J.S., De Laat R., Ieguchi K., Wiley J.C., Hudson M.P., Bothwell M. LINGO-1 interacts with the p75 neurotrophin receptor in intracellular membrane compartments. J. Biol. Chem. 2015, 290:9511-9520.
30. Mi S., Lee X., Shao Z., Thill G., Ji B., Relton J., Levesque M., Allaire N., Perrin S., Sands B., et al. LINGO-1 is a component of the Nogo-66 receptor/p75 signaling complex. Nat. Neurosci. 2004, 7:221-228.
31. Mi S., Miller R.H., Lee X., Scott M.L., Shulag-Morskaya S., Shao Z., Chang J., Thill G., Levesque M., Zhang M., et al. LINGO-1 negatively regulates myelination by oligodendrocytes. Nat. Neurosci. 2005, 8:745-751.
32. Puehringer D., Orel N., Lüningschrör P., Subramanian N., Herrmann T., Chao M.V., Sendtner M. EGF transactivation of Trk receptors regulates the migration of newborn cortical neurons. Nat. Neurosci. 2013, 16:407-415.
33. Rajagopal R., Chen Z.Y., Lee F.S., Chao M.V. Transactivation of Trk neurotrophin receptors by G-protein-coupled receptor ligands occurs on intracellular membranes. J. Neurosci. 2004, 24:6650-6658.
34. Rice H.C., Young-Pearse T.L., Selkoe D.J. Systematic evaluation of candidate ligands regulating ectodomain shedding of amyloid precursor protein. Biochemistry 2013, 52:3264-3277.
35. Schecterson L.C., Hudson M.P., Ko M., Philippidou P., Akmentin W., Wiley J., Rosenblum E., Chao M.V., Halegoua S., Bothwell M. Trk activation in the secretory pathway promotes Golgi fragmentation. Mol. Cell. Neurosci. 2010, 43:403-413.
36. Shattuck D.L., Miller J.K., Laederich M., Funes M., Petersen H., Carraway K.L., Sweeney C. LRIG1 is a novel negative regulator of the Met receptor and opposes Met and Her2 synergy. Mol. Cell. Biol. 2007, 27:1934-1946.
37. Stutz M.A., Shattuck D.L., Laederich M.B., Carraway K.L., Sweeney C. LRIG1 negatively regulates the oncogenic EGF receptor mutant EGFRvIII. Oncogene 2008, 27:5741-5752.
38. Tanemura A., Nagasawa T., Inui S., Itami S. LRIG-1 provides a novel prognostic predictor in squamous cell carcinoma of the skin: immunohistochemical analysis for 38 cases. Dermatol. Surg. 2005, 31:423-430.
39. Trifunovski A., Josephson A., Ringman A., Brené S., Spenger C., Olson L. Neuronal activity-induced regulation of Lingo-1. Neuroreport 2004, 15:2397-2400.
40. Valdez G., Philippidou P., Rosenbaum J., Akmentin W., Shao Y., Halegoua S. Trk-signaling endosomes are generated by Rac-dependent macroendocytosis. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:12270-12275.
41. Wang L.H., Rothberg K.G., Anderson R.G. Mis-assembly of clathrin lattices on endosomes reveals a regulatory switch for coated pit formation. J. Cell Biol. 1993, 123:1107-1117.
42. Wong V.W., Stange D.E., Page M.E., Buczacki S., Wabik A., Itami S., van de Wetering M., Poulsom R., Wright N.A., Trotter M.W., et al. Lrig1 controls intestinal stem-cell homeostasis by negative regulation of ErbB signalling. Nat. Cell Biol. 2012, 14:401-408.
43. Yu T., Calvo L., Anta B., López-Benito S., Southon E., Chao M.V., Tessarollo L., Arévalo J.C. Regulation of trafficking of activated TrkA is critical for NGF-mediated functions. Traffic 2011, 12:521-534.